about
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective.A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study.Targeted approaches to childhood cancer: progress in drug discovery and development.The development of targeted new agents to improve the outcome for children with leukemia.Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.Glioblastoma, 47XXY/45,X mosaicism, and hyperpigmented skin lesionsLong-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trialECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in SpainMRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic TreatmentImproving the quality of care in the molecular era for children and adolescents with medulloblastomaThe challenge of defining "ultra-high-risk" neuroblastomaHow to address challenges and opportunities in pediatric cancer drug development?
P50
Q30234441-3D5E6A97-510C-404F-9F5E-9C0A4E690ED4Q33418532-2A74A2E7-313C-4797-9D45-19AE93716307Q38404462-5815BF7C-5194-4108-BA0F-9D2F83B4857DQ38964974-F9AB9BCB-45A2-4D47-B3D1-094598441310Q47296254-062A628E-292C-45E0-BE28-6C4A4AAAE9F7Q90232620-E76D494C-D640-44AD-873A-1A238F37867DQ90269859-0E54CF06-2A16-4F23-BCA7-1FC7B284F642Q90623104-F799F8F1-4A0E-4664-9863-AC6136D599F6Q92402049-AB8BE97C-9326-4F7A-B104-668BE82F31D8Q92776108-273BC9E5-36A2-436D-9214-FC8CA9B38448Q93384994-C1702D42-EACB-438C-B278-A27FDA3F51FAQ95279673-6B3B9F4C-337B-4FB7-B0D2-2082FEA5CC06
P50
description
researcher
@en
wetenschapper
@nl
name
Lucas Moreno
@en
Lucas Moreno
@nl
type
label
Lucas Moreno
@en
Lucas Moreno
@nl
prefLabel
Lucas Moreno
@en
Lucas Moreno
@nl
P31
P496
0000-0002-0708-1670